Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Journal of Cancer|March 14, 2022
Identification of MICALL2 as a Novel Prognostic Biomarker Correlating with Inflammation and T Cell Exhaustion of Kidney Renal Clear Cell CarcinomaWenfeng Lin, Wenwei Chen, Jisheng Zhong, et al.
Urology|September 3, 2013
Percutaneous nephrolithotomy under local infiltration anesthesia: a single-center experience of 2000 Chinese casesHulin Li, Kai Xu, Bingkun Li, et al.
BMC Cancer|May 27, 2026
Transcriptomic analysis of genes in bladder cancer patients with resistance to neoadjuvant chemoimmunotherapyChunxiao Chen, Xincheng Liu, Abai Xu, et al.
Oncotarget|May 30, 2015
A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine modelKai Guo, Peng Huang, Naijin Xu, et al.
Iranian Journal of Public Health|October 21, 2024
Phosphorus Metabolism-Related Genes Serve as Novel Biomarkers for Predicting Prognosis in Bladder Cancer: A Bioinformatics AnalysisYang He, Abai Xu, Li Xiao, et al.
Journal of Endourology|July 25, 2013
A randomized trial comparing diode laser enucleation of the prostate with plasmakinetic enucleation and resection of the prostate for the treatment of benign prostatic hyperplasiaAbai Xu, Yong Zou, Bingkun Li, et al.
Medical Oncology (Northwood, London, England)|March 25, 2014
Percent free prostate-specific antigen does not improve the effectiveness of prostate cancer detection in Chinese men with a prostate-specific antigen of 2.5-20.0 ng/ml: a multicenter studyMaping Huang, Yurong Lin, Abai Xu, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|November 27, 2015
[Effect of stable DNA methyltransferase 3bknockdown on proliferation and apoptosis in bladder cancer cells in vitro]Ke Chen, Bing-Kun Li, Kai Xu, et al.
World Journal of Urology|July 6, 2016
Ligation-free technique for dorsal vascular complex control during laparoscopic radical prostatectomy: a single-center experience from ChinaPeng Xu, Abai Xu, Binshen Chen, et al.
International Journal of Biological Sciences|August 23, 2021
Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder CancerWenfeng Lin, Jingkai Sun, Takuya Sadahira, et al.
Pageof 8